216 related articles for article (PubMed ID: 16846654)
1. Expression, localization, and erythrocyte binding activity of Plasmodium yoelii merozoite surface protein-8.
Shi Q; Cernetich-Ott A; Lynch MM; Burns JM
Mol Biochem Parasitol; 2006 Oct; 149(2):231-41. PubMed ID: 16846654
[TBL] [Abstract][Full Text] [Related]
2. Alteration in host cell tropism limits the efficacy of immunization with a surface protein of malaria merozoites.
Shi Q; Cernetich A; Daly TM; Galvan G; Vaidya AB; Bergman LW; Burns JM
Infect Immun; 2005 Oct; 73(10):6363-71. PubMed ID: 16177307
[TBL] [Abstract][Full Text] [Related]
3. Enhanced protection against malaria by a chimeric merozoite surface protein vaccine.
Shi Q; Lynch MM; Romero M; Burns JM
Infect Immun; 2007 Mar; 75(3):1349-58. PubMed ID: 17158895
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of Plasmodium yoelii merozoite surface protein 4/5 produced in transgenic plants.
Wang L; Webster DE; Campbell AE; Dry IB; Wesselingh SL; Coppel RL
Int J Parasitol; 2008 Jan; 38(1):103-10. PubMed ID: 17681344
[TBL] [Abstract][Full Text] [Related]
5. Truncation of Plasmodium berghei merozoite surface protein 8 does not affect in vivo blood-stage development.
de Koning-Ward TF; Drew DR; Chesson JM; Beeson JG; Crabb BS
Mol Biochem Parasitol; 2008 May; 159(1):69-72. PubMed ID: 18359107
[TBL] [Abstract][Full Text] [Related]
6. Erythrocyte surface glycosylphosphatidyl inositol anchored receptor for the malaria parasite.
Rungruang T; Kaneko O; Murakami Y; Tsuboi T; Hamamoto H; Akimitsu N; Sekimizu K; Kinoshita T; Torii M
Mol Biochem Parasitol; 2005 Mar; 140(1):13-21. PubMed ID: 15694483
[TBL] [Abstract][Full Text] [Related]
7. Oral immunization with a combination of Plasmodium yoelii merozoite surface proteins 1 and 4/5 enhances protection against lethal malaria challenge.
Wang L; Goschnick MW; Coppel RL
Infect Immun; 2004 Oct; 72(10):6172-5. PubMed ID: 15385527
[TBL] [Abstract][Full Text] [Related]
8. Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite.
Kang Y; Calvo PA; Daly TM; Long CA
J Immunol; 1998 Oct; 161(8):4211-9. PubMed ID: 9780195
[TBL] [Abstract][Full Text] [Related]
9. Plasmodium yoelii: the role of the individual epidermal growth factor-like domains of the merozoite surface protein-1 in protection from malaria.
Calvo PA; Daly TM; Long CA
Exp Parasitol; 1996 Jan; 82(1):54-64. PubMed ID: 8617331
[TBL] [Abstract][Full Text] [Related]
10. Protective efficacy against malaria of a combination sporozoite and erythrocytic stage vaccine.
Wang R; Charoenvit Y; Daly TM; Long CA; Corradin G; Hoffman SL
Immunol Lett; 1996 Nov; 53(2-3):83-93. PubMed ID: 9024983
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium yoelii: peptide immunization induces protective CD4+ T cells against a previously unrecognized cryptic epitope of the circumsporozoite protein.
Takita-Sonoda Y; Tsuji M; Kamboj K; Nussenzweig RS; Clavijo P; Zavala F
Exp Parasitol; 1996 Nov; 84(2):223-30. PubMed ID: 8932772
[TBL] [Abstract][Full Text] [Related]
12. Active immunisation with RAMA does not provide protective immunity against Plasmodium yoelii challenge despite its association with protective responses in endemic populations.
Kats LM; Wang L; Murhandarwati EE; Mitri K; Black CG; Coppel RL
Vaccine; 2008 Jun; 26(26):3261-7. PubMed ID: 18468741
[TBL] [Abstract][Full Text] [Related]
13. Identifying merozoite surface protein 4 and merozoite surface protein 7 Plasmodium falciparum protein family members specifically binding to human erythrocytes suggests a new malarial parasite-redundant survival mechanism.
Garcia Y; Puentes A; Curtidor H; Cifuentes G; Reyes C; Barreto J; Moreno A; Patarroyo ME
J Med Chem; 2007 Nov; 50(23):5665-75. PubMed ID: 17944453
[TBL] [Abstract][Full Text] [Related]
14. Suppression of lethal Plasmodium yoelii malaria following protective immunization requires antibody-, IL-4-, and IFN-gamma-dependent responses induced by vaccination and/or challenge infection.
Petritus PM; Burns JM
J Immunol; 2008 Jan; 180(1):444-53. PubMed ID: 18097046
[TBL] [Abstract][Full Text] [Related]
15. Plasmodium yoelii: a differential fluorescent technique using Acridine Orange to identify infected erythrocytes and reticulocytes in Duffy knockout mouse.
Xu L; Chaudhuri A
Exp Parasitol; 2005 May; 110(1):80-7. PubMed ID: 15804382
[TBL] [Abstract][Full Text] [Related]
16. Critical role of Erythrocyte Binding-Like protein of the rodent malaria parasite Plasmodium yoelii to establish an irreversible connection with the erythrocyte during invasion.
Kegawa Y; Asada M; Ishizaki T; Yahata K; Kaneko O
Parasitol Int; 2018 Dec; 67(6):706-714. PubMed ID: 30025976
[TBL] [Abstract][Full Text] [Related]
17. Identification of karyopherin beta as an immunogenic antigen of the malaria parasite using immune mice and human sera.
Mohmmed A; Kishore S; Patra KP; Dasaradhi PV; Malhotra P; Chauhan VS
Parasite Immunol; 2005 May; 27(5):197-203. PubMed ID: 15987343
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium yoelii: experimental evidences for the conserved epitopes between mouse and human malaria parasite, Plasmodium falciparum.
Xu L; Pei X; Berzins K; Chaudhuri A
Exp Parasitol; 2007 Jul; 116(3):214-24. PubMed ID: 17336297
[TBL] [Abstract][Full Text] [Related]
19. NMR solution structure of NBD94(483-502) of the nucleotide-binding domain of the Plasmodium yoelii reticulocyte-binding protein Py235.
Basak S; Gayen S; Ramalingam JK; Grüber A; Preiser PR; Grüber G
FEMS Microbiol Lett; 2011 May; 318(2):152-8. PubMed ID: 21366672
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium yoelii uses the murine Duffy antigen receptor for chemokines as a receptor for normocyte invasion and an alternative receptor for reticulocyte invasion.
Swardson-Olver CJ; Dawson TC; Burnett RC; Peiper SC; Maeda N; Avery AC
Blood; 2002 Apr; 99(8):2677-84. PubMed ID: 11929753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
